Cargando…
The Landscape of the Advanced NSCLC Treatment Paradigm: Molecular Testing and Actionable Mutations
At JADPRO Live Virtual 2020, Rasheda Persinger, AGNP-C, explained the current lung cancer treatment landscape, including targeted therapies for EGFR and ALK rearrangements, as well as for BRAF, ROS1, NTRK, RET, MET, and KRAS mutations, and described the different testing modalities for molecular mar...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Harborside Press LLC
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8087227/ https://www.ncbi.nlm.nih.gov/pubmed/34084579 http://dx.doi.org/10.6004/jadpro.2021.12.3.17 |